David A. Horne, Ph.D.
Affiliations: | 1983-1988 | Chemistry | Massachusetts Institute of Technology, Cambridge, MA, United States |
| 2006- | City of Hope and Beckman Research Institute, USA |
Area:
Natural Products, Molecular MedicineWebsite:
https://www.cityofhope.org/people/horne-davidGoogle:
"David Horne"Bio:
Vice Provost and Associate Director, Beckman Research Institute
Mean distance: 8.01
Children
Sign in to add trainee| Christian Melander | grad student | Columbia (Microtree) | |
| Joseph Walter Chihade | grad student | 1991-1996 | Columbia |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Jana S, Krishna BM, Singhal J, et al. (2020) SOX9: The Master Regulator of Cell Fate in Breast Cancer. Biochemical Pharmacology. 113789 |
| Krishna BM, Jana S, Singhal J, et al. (2019) Notch signaling in breast cancer: From pathway analysis to therapy. Cancer Letters. 461: 123-131 |
| Wen W, Han ES, Dellinger TH, et al. (2019) Increasing Antitumor Activity of JAK Inhibitor by Simultaneous Blocking Multiple Survival Signaling Pathways in Human Ovarian Cancer. Translational Oncology. 12: 1015-1025 |
| Michalak SE, Nam S, Kwon DM, et al. (2019) A Chlorine-Atom-Controlled Terminal-Epoxide-Initiated Bicyclization Cascade Enables a Synthesis of the Potent Cytotoxins Haterumaimides J and K. Journal of the American Chemical Society |
| Singhal SS, Salgia R, Singhal S, et al. (2019) RLIP: An existential requirement for breast carcinogenesis. Biochimica Et Biophysica Acta. Reviews On Cancer. 1871: 281-288 |
| Nagaprashantha LD, Singhal J, Chikara S, et al. (2018) 2'-Hydroxyflavanone induced changes in the proteomic profile of breast cancer cells. Journal of Proteomics |
| Singhal J, Chikara S, Horne D, et al. (2018) 2'-Hydroxyflavanone inhibits in vitro and in vivo growth of breast cancer cells by targeting RLIP76. Molecular Carcinogenesis |
| Gu L, Lingeman RG, Yakushijin F, et al. (2018) The anti-cancer activity of a first-in-class small molecule targeting PCNA. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Nagaprashantha LD, Singhal J, Li H, et al. (2018) 2'-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer. Oncotarget. 9: 18053-18068 |
| Singhal J, Nagaprashantha L, Chikara S, et al. (2017) 2'-Hydroxyflavanone: A novel strategy for targeting breast cancer. Oncotarget. 8: 75025-75037 |